ABBVIE LTD - GB 

This institution has been merged with: ABBVIE INC.

Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2017 0 4.684.998 0 1
2016 0 6.000.000 0 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ELI LILLY AND COMPANY LIMITED2
JANSSEN PHARMACEUTICA NV2
NOVARTIS PHARMA2
ACTELION PHARMACEUTICALS1
AMGEN LIMITED1
ASTELLAS PHARMA EUROPE BV1
ASTRAZENECA AB1
BAYER PHARMA1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
CSL BEHRING1
DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
ERASMUS UNIVERSITEIT ROTTERDAM1
EUROPEAN CANCER PATIENT COALITION1
EUROPEAN PATIENTS' FORUM1
F HOFFMANNLA ROCHE1
FEDERAAL KENNISCENTRUM VOOR DE GEZONDHEIDSZORG1
H LUNDBECK AS1
IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON1
INSTITUT DE RECHERCHES SERVIER1
INSTITUTO TUMORI ""GIOVANNI PAOLO II""1
INTERNATIONAL ALLIANCE OF PATIENT'ORGANIZATIONS1
ISTITUTO EUROPEO DI ONCOLOGIA1
KATHOLIEKE UNIVERSITEIT LEUVEN1
MEDICAL RESEARCH COUNCIL1
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN1
MERCK SHARP & DOHME CORP1
MINDBYTES1
MUSCULAR DYSTROPHY GROUP OF GREAT BRITAIN AND NORTHERN IRELAND1
PFIZER LIMITED1
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT1
SCIPROM SARL1
STEINBEISSER PROJECT MANAGEMENT UG1
TAKEDA DEVELOPMENT CENTRE EUROPE1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE1
UNITED KINGDOM RESEARCH AND INNOVATION1
UNIVERSITAETSMEDIZIN GOETTINGEN GEORGAUGUSTUNIVERSITAET GOETTINGEN STIFTUNG OEFFENTLICHEN RECHTS1
UNIVERSITAIR MEDISCH CENTRUM UTRECHT1
UNIVERSITATSKLINIKUM ERLANGEN1
UNIVERSITE DE BORDEAUX1
UNIVERSITY OF AARHUS1
UNIVERSITY OF BIRMINGHAM1
UNIVERSITY OF DUNDEE1
UNIVERSITY OF NEWCASTLE UPON TYNE1
UPPSALA UNIVERSITET1
VIB1

Constancy:

Total number of partners: 50
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 50
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2017-03-01Inhibiting Misfolded protein PRopagation in Neurodegenerative Diseases - Sofia ref.: 116060 IMPRiNDparticipant4.684.99819
2016-10-01Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 PREFERparticipant6.000.00033